Document Type : Original Article
Acknowledgements: The authors would like to thank all the patients for their participation, the experts at the Research Centre of Mashhad Medical Sciences, Islamic Azad University, and all individuals who contributed to the completion of this study.
Availability of data and materials: All data generated or analyzed during this study are included in this published article.
Conflicts of interests: All authors declared that they have no competing interests.
Consent for publication: Not applicable.
Ethics approval and consent to participate: The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The Research Ethics Committee approved the study with ID number (IR.IAU.MSHD.REC.1402.161). Written informed consent was obtained from all participants included in the study.
Financial disclosure: No financial support was received for this study.
Author contributions: Conceptualization: ZM; Methodology and Formal analysis: ZM; Investigation and Data curation: RA and NJ; Writing – Original draft: RA, SM, and NJ; Writing – Review & Editing: ZM, RA, SM.
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
| 1. Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631-44. https://doi.org/10.1016/S0140-6736(10)60279-6 PMid:20598363 |
||||
| 2. Wisner K. Gestational hypertension and preeclampsia. MCN: The American Journal of Maternal/Child Nursing. 2019;44(3):170. https://doi.org/10.1097/NMC.0000000000000523 PMid:31033586 |
||||
| 3. Redman CW, Sargent IL. Immunology of preeclampsia. American journal of reproductive immunology. 2010;63(6):534-43. https://doi.org/10.1111/j.1600-0897.2010.00831.x PMid:20331588 |
||||
| 4. LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology. 2013;28(4):225-33. https://doi.org/10.1152/physiol.00006.2013 PMid:23817797 PMCid:PMC3742131 |
||||
| 5. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. Journal of Leukocyte Biology. 2013;94(2):247-57. https://doi.org/10.1189/jlb.1112603 PMid:23633414 |
||||
| 6. Han L, Liu X, Li H, Zou J, Yang Z, Han J, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PloS one. 2014;9(12):e114488. https://doi.org/10.1371/journal.pone.0114488 PMid:25464515 PMCid:PMC4252147 |
||||
| 7. Kim MA, Han GH, Kwon JY, Kim YH. Clinical significance of platelet‐to‐lymphocyte ratio in women with preeclampsia. American Journal of Reproductive Immunology. 2018;80(1):e12973. https://doi.org/10.1111/aji.12973 PMid:29781540 |
||||
| 8. Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? The journal of maternal-fetal & neonatal medicine. 2019;32(9):1412-9. https://doi.org/10.1080/14767058.2017.1410701 PMid:29179639 |
||||
| 9. Serin S, Avcı F, Ercan O, Köstü B, Bakacak M, Kıran H. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of preeclampsia? Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 2016;6(1):22-5. https://doi.org/10.1016/j.preghy.2016.01.005 PMid:26955767 |
||||
| 10. Thombare D, Bhalerao A, Dixit P, Joshi S, Dapkekar P, Thombare Jr D. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Antenatal Women With Preeclampsia: A Case-Control Study. Cureus. 2023;15(6). https://doi.org/10.7759/cureus.40338 |
||||
| 11. Zhuang Y, Xiao Y, Bai R, Song Y, Lin Z, Yu Y, et al. The association of peripheral blood immunoinflammatory markers with PE and adverse outcomes in preeclampsia: a retrospective study. Journal of Inflammation Research. 2025:4359-66. https://doi.org/10.2147/JIR.S504552 PMid:40162079 PMCid:PMC11954471 |
||||
| 12. Khan JA, Ashraf A, Qureshi W, Fayaz F. Neutrophil-lymphocyte ratio as inflammatory marker for clinical prediction and disease severity evaluation of preeclampsia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 12(2):449. https://doi.org/10.18203/2320-1770.ijrcog20230133 |
||||
| 13. Toptas M, Asik H, Kalyoncuoglu M, Can E, Can MM. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio predictors for severity of preeclampsia? Journal of Clinical Gynecology and Obstetrics. 2016;5(1):27-31. https://doi.org/10.14740/jcgo389w |
||||
| 14. Yavuzcan A, Caglar M, Ustun Y, Dilbaz S, Yidiz E, Ozbilgec S, et al. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekologia polska. 2014;85(3). https://doi.org/10.17772/gp/1713 |
||||
| 15. Kang Q, Li W, Yu N, Fan L, Zhang Y, Sha M, et al. Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients. Pregnancy hypertension. 2020;20:111-8. https://doi.org/10.1016/j.preghy.2020.03.009 PMid:32279029 |
||||
| 16. Wang J, Zhu Q-W, Cheng X-Y, Liu J-y, Zhang L-l, Tao Y-M, et al. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. Journal of reproductive immunology. 2019;132:29-34 https://doi.org/10.1016/j.jri.2019.02.001 PMid:30861482 |
||||